Intelligencer
The Cut
Vulture
The Strategist
Curbed
Grub Street
Magazine
Subscribe to the Magazine
Give a Gift Subscription
Buy Back Issues
Current Issue Contents
New York
Shop
Subscribe
Sign In
Account
Profile
Sign Out
Subscribe
Give A
Gift
Displaying all articles tagged:
Big Pharma
corporate america
Feb. 21, 2022
This Is How Big Pharma Wins
Two years into the pandemic, the industry has evaded reforms a supermajority of voters want.
By
Alexander Zaitchik
the naming of things
Aug. 23, 2021
What Is Up With the Brand Name for Pfizer’s COVID Vaccine?
The shot has a new name, Comirnaty, now that it’s FDA approved. But brand-naming experts aren’t sure people will use the name or remember it.
By
Choire Sicha
just asking questions
Apr. 30, 2020
Why Humanity Will Probably Botch the Next Pandemic, Too
A conversation with Mike Davis, author of 2005’s
The Monster at Our Door: The Global Threat of Avian Flu
, about nationalism, capitalism, and COVID-19.
By
Eric Levitz
trade
Dec. 5, 2019
Trump Mulls Throwing Big Pharma Under the Bus to Save NAFTA 2.0
The U.S. has long used trade deals as an excuse to export America’s high drug prices. Trump is reportedly willing to back away from that tradition.
By
Eric Levitz
polls
Aug. 30, 2019
Here Are 7 ‘Left Wing’ Ideas (Almost) All Americans Can Get Behind
New polling finds that several supposedly radical policy ideas actually command majority support — in all 50 states.
By
Eric Levitz
the republican party
July 12, 2019
Why the GOP Might Learn to Love Putting Price Controls on Drugs
Conservatives’ traditional defense of America’s high drug prices is completely at odds with Trump’s “America first” ideology.
By
Eric Levitz
trade
Mar. 29, 2019
Trump’s NAFTA 2.0 Puts Big Pharma First, America Second
Trump says lowering pharmaceutical prices is a priority. But his trade deal would bar Congress from curtailing patent monopolies on biologic drugs.
By
Eric Levitz
July 24, 2017
Democrats Unveil Populist Economic Agenda for 2018
The Donkey Party promises to secure Americans a “better deal” by taking on Big Pharma and concentrated corporate power.
By
Eric Levitz
May 31, 2017
Ohio Sues 5 Drug Companies for Fueling the Opioid Epidemic
The firms knowingly misled doctors and patients about the risks inherent to opioid painkillers, the lawsuit alleges.
By
Eric Levitz
Feb. 3, 2017
Company Raises Price of Opioid-Overdose Antidote by 500 Percent, to $4,500
Earlier this week, President Trump backed off his pledge to bargain with drug companies over their prices.
By
Eric Levitz
Dec. 21, 2016
The Opioid Epidemic Is a Symptom of Toxic Greed
Our system of financing drug research gave the makers of OxyContin a multibillion-dollar incentive to ignore the risks their drug posed.
By
Eric Levitz
early and often
Dec. 1, 2016
House Passes Sweeping, Controversial Health Innovation Bill
It means big changes for the National Institutes of Health and the Food and Drug Administration, and not everyone is pleased.
By
Charley Lanyon
Oct. 17, 2016
Investors Seem to Think Hillary Clinton Really Will Take On Big Pharma
As Clinton’s electoral odds rise, the value of health-care stocks goes down.
By
Eric Levitz
Sept. 21, 2016
Democrats and Republicans Unite to Rip Mylan CEO for EpiPen Price Hikes
Finally, something they can agree on.
By
Adam K. Raymond
Aug. 25, 2016
CEO Innovated Her Way to a Higher Salary by Disrupting Price of Drug for Kids
Only in America.
By
Eric Levitz
June 20, 2016
Doctors Will Prescribe Branded Drugs for Food, Study Finds
Doctors who accept free meals from a pharmaceutical company are more likely to prescribe that company’s drug over the generic — even when the meal costs less than $20.
By
Eric Levitz
Feb. 4, 2016
Martin Shkreli Pleads the Fifth in Hearing
Followed by a smug tweet.
By
Claire Landsbaum
Feb. 3, 2016
Martin Shkreli’s Company Memos Confirm He’s a Human Garbage Monster
“Nice work, as usual. $1 billion here we come.”
By
Claire Landsbaum
the money
Jan. 13, 2016
How Valeant Went From Wall St. Darling to Pariah
Inside the biggest and most bizarre business scandal of the past year.
By
Stephen Witt
Dec. 4, 2015
Shkreli: I Would Have Raised Prices Higher
Sure, everyone worries about the dying cancer patients. But what about Martin Shkreli’s shareholders?
By
Ben Ellman
plot twists
Oct. 23, 2015
Martin Shkreli’s Super-Expensive Drug Has a New, Cheap Competitor
Turing Pharmaceuticals just got disrupted.
By
Eric Levitz
bad drugs
Oct. 26, 2010
GlaxoSmithKline Pays $750 Million Fine for Selling Shoddy Drugs
In a settlement with the Justice Department, it admits that it knowingly sold contaminated drugs made at a Puerto Rican factory.
By
Avi Zenilman
health carnage
Oct. 19, 2010
Big Pharma Hires Bad Doctors: ‘Maybe I Am a Pervert, I Honestly Don’t Know’
ProPublica investigates big pharma’s payroll.
By
Nitasha Tiku